The National Multiple Sclerosis Society has committed nearly $14 million to support 40 new MS research projects. These are part of a comprehensive approach to accelerate research breakthroughs aimed at stopping MS, restoring lost function, and ending the disease.
This financial commitment is the latest in the Society's research effort, investing $40 million in 2017 alone for new and ongoing studies around the globe. The Society stimulates studies worldwide, leverages opportunities, fosters collaboration, and shapes the research landscape to address the urgent needs of people with MS.
Just a few of the of the new cutting-edge research projects include a clinical trial at Oregon Health & Science University to determine if an oral antioxidant can slow progressive MS; a study by researchers at the University of Connecticut and University of Paris using cutting-edge technology to explore a novel way to repair nerve-insulating myelin to restore function; and a study at the University of Utah to determine whether exercises can improve balance in people living with MS.
"These important new research investments are part of the Society's comprehensive approach to address our most pressing research priorities and to accelerate breakthroughs that change the world for people with MS," said Bruce Bebo, PhD, National MS Society's Executive Vice President, Research.
To find the best research with the most promise, the Society relies on more than 130 scientists who volunteer their time to evaluate hundreds of proposals every year. This evaluation process assures that Society funds fuel research that delivers results in the shortest time possible.